JP2002502827A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002502827A5 JP2002502827A5 JP2000530232A JP2000530232A JP2002502827A5 JP 2002502827 A5 JP2002502827 A5 JP 2002502827A5 JP 2000530232 A JP2000530232 A JP 2000530232A JP 2000530232 A JP2000530232 A JP 2000530232A JP 2002502827 A5 JP2002502827 A5 JP 2002502827A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- immunodeficiency virus
- human immunodeficiency
- protein
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229960005486 vaccine Drugs 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 7
- 241000725303 Human immunodeficiency virus Species 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 101000992180 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) Outer membrane protein Omp38 Proteins 0.000 description 1
- 101001086530 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Outer membrane protein P5 Proteins 0.000 description 1
- 108010048209 Human Immunodeficiency Virus Proteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 230000005867 T cell response Effects 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7394398P | 1998-02-06 | 1998-02-06 | |
| US60/073,943 | 1998-02-06 | ||
| PCT/US1999/002503 WO1999039735A1 (en) | 1998-02-06 | 1999-02-04 | Live vaccine for human immunodeficiency virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002502827A JP2002502827A (ja) | 2002-01-29 |
| JP2002502827A5 true JP2002502827A5 (enExample) | 2006-03-23 |
Family
ID=22116747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000530232A Withdrawn JP2002502827A (ja) | 1998-02-06 | 1999-02-04 | ヒト免疫不全ウイルスに対する生ワクチン |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1061950B1 (enExample) |
| JP (1) | JP2002502827A (enExample) |
| KR (1) | KR20010040618A (enExample) |
| CN (1) | CN1216640C (enExample) |
| AT (1) | ATE287727T1 (enExample) |
| AU (1) | AU744730B2 (enExample) |
| CA (1) | CA2320489A1 (enExample) |
| DE (1) | DE69923439D1 (enExample) |
| IL (1) | IL137680A0 (enExample) |
| NZ (1) | NZ506093A (enExample) |
| RU (1) | RU2223784C2 (enExample) |
| WO (1) | WO1999039735A1 (enExample) |
| ZA (1) | ZA99912B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2802426B1 (fr) * | 1999-12-15 | 2004-04-02 | Neovacs | Utilisation de proteines immunogenes immunosuppressives et/ou angiogeniques rendues inactives, pour la production d'iga secretoires |
| CN1549726A (zh) * | 2000-07-31 | 2004-11-24 | 耶鲁大学 | 先天性免疫系统指导的疫苗 |
| KR100447530B1 (ko) * | 2001-08-14 | 2004-09-08 | 한국과학기술원 | ＯｍｐＦ를 이용하여 목적 단백질을 대장균 세포외로분비생산하는 방법 |
| EP1670505B1 (en) * | 2003-09-18 | 2012-11-14 | GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Dna promoters and anthrax vaccines |
| EP1991264B1 (en) | 2006-03-07 | 2015-01-07 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| CN101195823B (zh) * | 2007-11-20 | 2010-06-02 | 华东理工大学 | 细菌表面展示系统、方法及应用 |
| CN109207417A (zh) * | 2018-09-19 | 2019-01-15 | 湖北省农业科学院畜牧兽医研究所 | 鸡白痢-j亚群禽白血病双重平板凝集抗原及其制备方法 |
| WO2021178888A1 (en) * | 2020-03-05 | 2021-09-10 | University Of Maryland, Baltimore | Live salmonella typhi vectors engineered to express cancer protein antigens and methods of use thereof |
| WO2025063261A1 (ja) * | 2023-09-22 | 2025-03-27 | 塩野義製薬株式会社 | ウイルス由来タンパク質をコードするポリヌクレオチド |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4757013A (en) * | 1983-07-25 | 1988-07-12 | The Research Foundation Of State University Of New York | Cloning vehicles for polypeptide expression in microbial hosts |
| EP0563323A4 (en) * | 1990-12-19 | 1996-02-28 | Epitope Inc | Hiv reverse transcriptase vaccine |
| JP3100005B2 (ja) * | 1992-07-28 | 2000-10-16 | 雪印乳業株式会社 | ヒト免疫不全ウィルス感染・増殖抑制剤 |
| WO1996011708A1 (en) * | 1994-10-18 | 1996-04-25 | Board Of Regents, The University Of Texas System | Membrane expression of heterologous genes |
-
1999
- 1999-02-04 EP EP99913808A patent/EP1061950B1/en not_active Expired - Lifetime
- 1999-02-04 KR KR1020007008489A patent/KR20010040618A/ko not_active Abandoned
- 1999-02-04 DE DE69923439T patent/DE69923439D1/de not_active Expired - Fee Related
- 1999-02-04 RU RU2000123173/15A patent/RU2223784C2/ru not_active IP Right Cessation
- 1999-02-04 AT AT99913808T patent/ATE287727T1/de not_active IP Right Cessation
- 1999-02-04 JP JP2000530232A patent/JP2002502827A/ja not_active Withdrawn
- 1999-02-04 CN CN998027014A patent/CN1216640C/zh not_active Expired - Fee Related
- 1999-02-04 NZ NZ506093A patent/NZ506093A/en unknown
- 1999-02-04 AU AU31801/99A patent/AU744730B2/en not_active Ceased
- 1999-02-04 WO PCT/US1999/002503 patent/WO1999039735A1/en not_active Ceased
- 1999-02-04 CA CA002320489A patent/CA2320489A1/en not_active Abandoned
- 1999-02-04 IL IL13768099A patent/IL137680A0/xx unknown
- 1999-02-05 ZA ZA9900912A patent/ZA99912B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0732937B2 (en) | Non-toxic mucosal adjuvant | |
| Tacket et al. | Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159: H4 | |
| Almeida et al. | Nasal delivery of vaccines | |
| US6126938A (en) | Methods for inducing a mucosal immune response | |
| JP7426953B2 (ja) | 免疫原性組成物 | |
| JP2004159660A (ja) | コレラワクチンとしての欠失変異体 | |
| JP2004512264A5 (enExample) | ||
| JP2002502827A5 (enExample) | ||
| HK1003229A1 (en) | Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine | |
| HK1003229B (en) | Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine | |
| Poles et al. | Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection | |
| RU2000123173A (ru) | Живая вакцина против вируса иммунодефицита человека | |
| Yang et al. | Metabolic engineering of Lactobacilli spp. for disease treatment | |
| Stevceva et al. | Mucosal HIV vaccines: where are we now? | |
| CN101455846B (zh) | 脱乙酰壳聚糖递送系统组装的结核基因疫苗及其制备和应用 | |
| RU2223784C2 (ru) | Живая вакцина против вируса иммунодефицита человека | |
| US20090324638A1 (en) | Live bacterial vaccine | |
| KR101187625B1 (ko) | 경구 투여 백신 | |
| JP6216371B2 (ja) | ＹｅｒｓｉｎｉａｐｅｓｔｉｓＦ１−Ｖ融合タンパク質を発現するＳａｌｍｏｎｅｌｌａＴｙｐｈｉＴｙ２１ａおよびその使用 | |
| Chamcha | Probiotics based approaches to target mucosal compartments: Potential novel approaches to HIV vaccine development | |
| JP5148577B2 (ja) | 非毒性の粘膜アジュバント | |
| GB2413327A (en) | Fusion proteins comprising E. coli antigens | |
| Vajdy | Induction of optimal immune responses against human immunodeficiency virus at mucosal portals of entry | |
| JP2002507118A (ja) | ヘリコバクターピロリＦｌｇＥポリペプチドからなるワクチン組成物 | |
| JP4875606B2 (ja) | ストレプトミセスから得られたワクチン組成物 |